In conclusion, our study reveals a higher CBZ clearance in the presence of the ABCB1 1236T-2677T-3435T haplotype in pediatric epileptic patients, supporting the potential of personalized medicine in optimizing epilepsy treatment. This evidence concerns the gene ABCB1 and epilepsy.